Novartis Shareholders Give Green Light To Sandoz Spinoff
Separation Of Standalone Generics And Biosimilars Firm Expected To Proceed On 4 October
• By David Wallace
Novartis shareholders have given the go-ahead to spin off Sandoz • Source: Shutterstock 
